PTPLB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.232000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.806400E-01
Normal-vs-Stage2
6.893800E-01
Normal-vs-Stage3
4.393400E-01
Normal-vs-Stage4
3.866800E-01
Stage1-vs-Stage2
7.441600E-01
Stage1-vs-Stage3
1.949360E-01
Stage1-vs-Stage4
5.016200E-01
Stage2-vs-Stage3
2.028400E-01
Stage2-vs-Stage4
1.812630E-01
Stage3-vs-Stage4
1.595170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.503600E-01
Normal-vs-AfricanAmerican
4.003000E-01
Normal-vs-Asian
9.421800E-01
Caucasian-vs-AfricanAmerican
3.158200E-01
Caucasian-vs-Asian
8.202600E-01
AfricanAmerican-vs-Asian
4.747400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.256400E-01
Normal-vs-Female
7.313600E-01
Male-vs-Female
9.853400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.634800E-01
Normal-vs-Age(41-60Yrs)
4.669600E-01
Normal-vs-Age(61-80Yrs)
8.930200E-01
Normal-vs-Age(81-100Yrs)
9.589400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.457000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.552600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.315800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.507910E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.112200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.104000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.040400E-01
Normal-vs-Daily Drinker
7.923600E-01
Normal-vs-Weekly Drinker
9.973200E-01
Normal-vs-Occasional Drinker
4.580800E-01
Normal-vs-Social Drinker
6.615600E-01
Non Drinker-vs-Daily Drinker
2.965000E-01
Non Drinker-vs-Weekly Drinker
6.227800E-01
Non Drinker-vs-Occasional Drinker
2.640800E-01
Non Drinker-vs-Social Drinker
8.064400E-01
Daily Drinker-vs-Weekly Drinker
6.258800E-01
Daily Drinker-vs-Occasional Drinker
4.056300E-02
Daily Drinker-vs-Social Drinker
1.939200E-01
Weekly Drinker-vs-Occasional Drinker
1.479170E-01
Weekly Drinker-vs-Social Drinker
4.367000E-01
Occasional Drinker-vs-Social Drinker
4.228200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.241400E-01
Normal-vs-Grade 2
1.038200E-01
Normal-vs-Grade 3
6.770100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.700100E-02
Grade 1-vs-Grade 3
6.575500E-03
Grade 1-vs-Grade 4
2.241400E-01
Grade 2-vs-Grade 3
8.364000E-02
Grade 2-vs-Grade 4
1.038200E-01
Grade 3-vs-Grade 4
6.770100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.725800E-01
Normal-vs-NonDiabetic
8.179800E-01
Diabetic-vs-NonDiabetic
5.105400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.390600E-01
Normal-vs-NoPancreatitis
7.850800E-01
Pancreatitis-vs-NoPancreatitis
1.195950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.016200E-01
Normal-vs-N1
6.657800E-01
N0-vs-N1
5.980000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.453800E-01
Normal-vs-TP53-NonMutant
6.833000E-01
TP53-Mutant-vs-TP53-NonMutant
8.489600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
